Register for our free email digests:
Latest From Applied Therapeutics Inc.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in January and February 2017.
Finance Watch: Surrozen Raises $33m In $483m February Flurry; Also, Are Reverse Mergers This Year's IPOs?
Surrozen raised $33m to fund drug development programs targeting Wnt ligands for various indications during a February VC financing flurry that occurred despite a drop in IPOs. Taking an alternative route to going public, some biopharma companies have completed reverse mergers in recent weeks and months.
Drug Discovery Tools
- Natural Products
- Drug Discovery Tools
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- Tetragenetics Inc.
- Senior Management
Kevin O'Brien, CFO
Theodore Clark, PhD, CSO
John P Reilly, VP, Bus. Dev.
- Contact Info
Phone: (617) 500-7471
85 Bolton St.
Cambridge, MA 02140
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.